10-K Decoder · All companies

Edwards Lifesciences Corporation

EW · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$6.07B$5.44B+11.5%
Operating income$1.26B$1.38B−8.3%
Net income$1.07B$4.17B−74.3%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$1.72B$1.55B+10.5%
Operating income$299M$307M−2.6%
Net income$308M$291M+5.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Edwards's revenue in FY2025?
$6.07B in FY2025 (Fiscal year ended Dec 31, 2025), +11.5% vs $5.44B a year earlier, per its 10-K filed Feb 2026.
Was Edwards profitable in FY2025?
Yes: net income was $1.07B and operating income $1.26B in FY2025.
What was Edwards's revenue in Q3 2026?
$1.72B (+10.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.